APA (7th ed.) Citation

A, M., AM, S., RR, N., AJ, S., R, N., J, S., & R, B. (2017). Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors. The Journal of neuroscience : the official journal of the Society for Neuroscience, 37(44), 10587. https://doi.org/10.1523/JNEUROSCI.2211-17.2017

Chicago Style (17th ed.) Citation

A, Melo-Carrillo, Strassman AM, Nir RR, Schain AJ, Noseda R, Stratton J, and Burstein R. "Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors." The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 37, no. 44 (2017): 10587. https://doi.org/10.1523/JNEUROSCI.2211-17.2017.

MLA (9th ed.) Citation

A, Melo-Carrillo, et al. "Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors." The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, vol. 37, no. 44, 2017, p. 10587, https://doi.org/10.1523/JNEUROSCI.2211-17.2017.